Cargando…
Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malaria
Despite inadequacy in preventing vivax malaria after travel, suppressive chemoprophylaxis has dominated travel medicine strategy since the advent of chloroquine in 1946. The lethal threat of falciparum malaria versus the perceived benign consequence of vivax malaria underpins this strategic posture....
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Science
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659284/ https://www.ncbi.nlm.nih.gov/pubmed/23454204 http://dx.doi.org/10.1016/j.tmaid.2013.01.002 |